Clinical Trial Update: Raptiva and Sirolimus in Islet Transplantation for Type 1 Diabetes [Phase 1, Phase 2]

View source ↗

Summary

Terminated Phase 1/2 trial evaluating islet transplantation for Type 1 diabetes using efalizumab (Raptiva) and sirolimus; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoglycemia
• Type 1 Diabetes Mellitus

Drugs mentioned

• Rapamune (sirolimus)
• Raptiva (efalizumab)

Snippet

Sponsor: University of Minnesota | Conditions: Type 1 Diabetes Mellitus, Hypoglycemia | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2013-03-27